alprenolol and sb 203580

alprenolol has been researched along with sb 203580 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Genade, S; Lochner, A; Marais, E; Moolman, JA; Strijdom, H	1

Other Studies

1 other study(ies) available for alprenolol and sb 203580

Article	Year
p38 MAPK activation triggers pharmacologically-induced beta-adrenergic preconditioning, but not ischaemic preconditioning. Journal of molecular and cellular cardiology, 2001, Volume: 33, Issue:12 Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Alprenolol; Animals; Enzyme Activation; Enzyme Inhibitors; Imidazoles; Ischemic Preconditioning, Myocardial; Isoproterenol; Male; Mitogen-Activated Protein Kinases; Myocardial Ischemia; Myocardial Reperfusion; p38 Mitogen-Activated Protein Kinases; Perfusion; Phosphorylation; Pyridines; Rats; Rats, Wistar; Receptors, Adrenergic, beta	2001

Article

Year

p38 MAPK activation triggers pharmacologically-induced beta-adrenergic preconditioning, but not ischaemic preconditioning.

Journal of molecular and cellular cardiology, 2001, Volume: 33, Issue:12

Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Alprenolol; Animals; Enzyme Activation; Enzyme Inhibitors; Imidazoles; Ischemic Preconditioning, Myocardial; Isoproterenol; Male; Mitogen-Activated Protein Kinases; Myocardial Ischemia; Myocardial Reperfusion; p38 Mitogen-Activated Protein Kinases; Perfusion; Phosphorylation; Pyridines; Rats; Rats, Wistar; Receptors, Adrenergic, beta

2001